Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1394595 | European Journal of Medicinal Chemistry | 2011 | 9 Pages |
Designed and synthesized were a series of 5H-chromeno[4,3-b]pyridines with substitution at 2- and 4-positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Structure–activity relationship study showed that 2-furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slideHighlights► Twenty three conformationally constrained rigid 2,4-diaryl chromenopyridines were synthesized for topo I and II inhibitors. ► Compounds 15, 24, 27, and 28 displayed significant topo I inhibitory activity. ► Compounds 14, 15, 26, and 36 exhibited moderate topo II inhibitory activity. ► Compounds 24, 26, and 28 exhibited strong cytotoxicity. ► 2- Furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity.